Inverse-electron-demand Diels-Alder reac
✍
Rüdiger Pipkorn; Waldemar Waldeck; Bernd Didinger; Mario Koch; Gabriele Mueller;
📂
Article
📅
2009
🏛
John Wiley and Sons
🌐
English
⚖ 230 KB
## Abstract Hormone‐refractory prostate cancer (HRPC), insensitive to most cytostatic interventions, features low response rates and bad prognosis. Studies with HRPC treated with temozolomide (TMZ) showed a poor response and the results were discouraging. Therefore, TMZ has been considered to be in